Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Myelodysplastic Syndromes (MDS)

Cleveland Clinic Investigator Proposes Relaxing Eligibility Criteria for MDS Clinical Trial Participation

Recently the Cleveland Clinic’s Abby Statler discussed eligibility criteria exclusions for MDS clinical trials. She reports that observed outcomes indicate […]

Cleveland Clinic Investigator Proposes Relaxing Eligibility Criteria for MDS Clinical Trial Participation
1 year ago
Share

Dana-Farber Cancer Institute Receives $5M for Myelodysplastic Syndromes Research

The Dana-Farber Cancer Institute has received a $5 million gift from the Edward P. Evans Foundation in support of research […]

1 year ago
Share

FDA grants Orphan Drug and Fast Track Status to Aprea Therapeutics’ APR-246 in Myelodysplastic Syndromes

Aprea Therapeutics announced APR-246, which targets the tumor suppressor protein p53, has been granted Fast Track designation by the FDA […]

Primary Children’s Hospital Utah to Test Effectiveness of Old Drug to Step Bleeding in Severely Injured Children
2 years ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.